ABC


The outlook for antibodies against oncology targets is exploding with the discovery of novel targets and the ability to effectively modulate the immune system. This meeting will investigate current trends in identifying, validating and developing antibody drugs for oncology. We will highlight antibodies in clinical development, the advancement of novel constructs and identification of successful strategies in the use of antibodies for immunotherapy. Plan to attend to network and hear about exciting developments from leaders in the community.

Learn how to:

  • Discover and validate emerging targets in cancer therapy and immunotherapy
  • Review candidates in the clinic
  • Explore immunomodulatory antibodies
  • Evaluate computational tools and animal models for cancer antibodies
  • Investigate translational studies for advancing antibody drugs
  • Assess the promise and challenges of novel constructs including ADCs

Scientists who wish to present their knowledge and expertise to their colleagues are asked to click here to submit a proposal.  Remember to specify the conference that you are interested in and please provide your full contact information.

The deadline for submission is Friday, September 25, 2015.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.  Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

For partnering and sponsorship information, please contact:

Christina Lingham
Executive Director, Conferences
Phone: 781-972-5464
E: clingham@healthtech.com    

Jason Gerardi
(Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: 781-972-5452
E: jgerardi@healthtech.com

Carol Dinerstein
(Companies L-Z)
Director, Business Development
Cambridge Healthtech Institute
T: 781.972.5471
E: dinerstein@healthtech.com